Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
doi: 10.1016/j.jep.2016.01.001 228 OyenihiABAhianteBOOyenihiORMasolaB
Biomed Res Int 2016:3423685
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
It is less clear why the FDA is requiring a specific cardiovascular study on higher-than-normal levels of exenatide, Bydureons active ingredient we were quite surprised and disappointed by this news, which seems difficult to justify given other drugs on the market with similar questions that have been approved
US$ 23.83
US$ 27.68
US$ 24.43
US$ 22.41
US$ 24.87
